alkenes has been researched along with Degenerative Diseases, Central Nervous System in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barber, DS; Gavin, T; Lopachin, RM | 1 |
Gavin, T; Lopachin, RM | 1 |
Bull, JA; Charette, AB; Fortier, A; Ladd, CL; Mousseau, JJ; Sustac Roman, D | 1 |
2 review(s) available for alkenes and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Type-2 alkenes mediate synaptotoxicity in neurodegenerative diseases.
Topics: Alkenes; Animals; Humans; Models, Biological; Neurodegenerative Diseases; Synapses | 2008 |
Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.
Topics: Acrylamide; Alkenes; Alzheimer Disease; Animals; Humans; Nerve Degeneration; Nerve Endings; Nervous System Diseases; Neurodegenerative Diseases; Nitric Oxide; Occupational Exposure | 2008 |
1 other study(ies) available for alkenes and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Synthesis of 2- and 2,3-substituted pyrazolo[1,5-a]pyridines: scope and mechanistic considerations of a domino direct alkynylation and cyclization of N-iminopyridinium ylides using alkenyl bromides, alkenyl iodides, and alkynes.
Topics: Alkenes; Alkynes; Bromides; Catalysis; Chemistry, Pharmaceutical; Cyclization; Dopamine Agonists; Dopamine Antagonists; Humans; Iodides; Magnetic Resonance Spectroscopy; Neurodegenerative Diseases; Palladium; Pyrazoles; Pyridines; Receptors, Dopamine; Silver | 2011 |